Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-075021
Filing Date
2011-08-09
Accepted
2011-08-09 15:08:09
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f59355e10vq.htm 10-Q 499835
2 EX-31.1 f59355exv31w1.htm EX-31.1 7124
3 EX-31.2 f59355exv31w2.htm EX-31.2 7443
4 EX-32.1 f59355exv32w1.htm EX-32.1 6181
  Complete submission text file 0000950123-11-075021.txt   4464918

Data Files

Seq Description Document Type Size
5 EX-101 INSTANCE DOCUMENT onxx-20110630.xml EX-101.INS 669969
6 EX-101 SCHEMA DOCUMENT onxx-20110630.xsd EX-101.SCH 43684
7 EX-101 CALCULATION LINKBASE DOCUMENT onxx-20110630_cal.xml EX-101.CAL 61129
8 EX-101 LABELS LINKBASE DOCUMENT onxx-20110630_lab.xml EX-101.LAB 339557
9 EX-101 PRESENTATION LINKBASE DOCUMENT onxx-20110630_pre.xml EX-101.PRE 240050
10 EX-101 DEFINITION LINKBASE DOCUMENT onxx-20110630_def.xml EX-101.DEF 114177
Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28298 | Film No.: 111020460
SIC: 2836 Biological Products, (No Diagnostic Substances)